Five things to know:
1. Fourth-quarter net loss decreased from $9.5 million to $8.6 million, representing a 9.5 percent decrease year-over-year.
2. SeaSpine reported $159.1 million in full-year 2019 revenue, which is an 11 percent increase compared to 2018.
3. U.S. revenue increased 16 percent year-over-year to $39.3 million.
4. Domestic spinal implants revenue consisted of $19.1 million of U.S. revenue, which increased 21 percent year-over-year.
5. Domestic orthobiologics revenue increased 11 percent to $20.2 million, representing an 11 percent increase year-over-year.
More articles on devices:
Zimmer Biomet cervical disc surpasses 150,000 implants
Orthofix’s positive Q4 can’t eclipse $28M 2019 loss
SASpine partners with Dr. Stanley Jones, establishes new location
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.